OCTOBER 19TH, 2022 CONN HASTINGSDIAGNOSTICS, GERIATRICS, MEDICINE, NEUROLOGY Researchers at Hokkaido University in Japan have developed a biomarker test for Alzheimer’s disease that detects amyloid β binding exosomes in a blood sample. While amyloid β plaques in the brain are characteristic of Alzheimer’s, these researchers have previously reported that amyloid β build-up in the brain...
